C68 DCF Valuation - Crescent Biopharma Inc

Watchlist Manager

Watchlist

Price: 15.9 EUR 7.43% Market Closed

Market Cap: €220.9m

	Crescent Biopharma Inc F:C68	US
	MatsukiyoCocokara & Co TSE:3088	JP
	Ventia Services Group Ltd ASX:VNT	AU
	A-Living Smart City Services Co Ltd F:1V0	CN
	Ares Capital Corp NASDAQ:ARCC	US
B	Baker Hughes Co NASDAQ:BKR	US
	Unipol Gruppo SpA MIL:UNI	IT
L	Liaoning Port Co Ltd F:D7P	CN
	Cardinal Health Inc NYSE:CAH	US
	On Holding AG NYSE:ONON	CH
	Samsung Electronics Co Ltd F:SSU	KR
	Finward Bancorp NASDAQ:FNWD	US
	Nanofilm Technologies International Ltd SGX:MZH	SG
	Sohgo Security Services Co Ltd TSE:2331	JP
	New China Life Insurance Co Ltd OTC:NWWCF	CN
	Toronto-Dominion Bank TSX:TD	CA
M	Muninova Holdings Inc TSE:547A	JP
	Halma PLC LSE:HLMA	UK
	Shiseido Co Ltd F:SHDA	JP
B	Bid Corporation Ltd JSE:BID	ZA
	Palantir Technologies Inc NASDAQ:PLTR	US
S	Sonic Automotive Inc F:SA8A	US
A	Atlantia SpA F:AU9	IT
V	ViacomCBS Inc LSE:0A65	US

C68's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.